Research governance
The impact of clinical trials legislation on clinical pharmacology
Orphan drug development is not taking off
Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori
Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity
Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
The pharmacokinetics and pharmacodynamics of warfarin in combination with ambrisentan in healthy volunteers
Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil
Effects of Schisandra sphenanthera extract on the pharmacokinetics of midazolam in healthy volunteers
Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus
Comparing patients' and healthcare professionals' ADR reports after media attention
Determinants of the drug utilization profile in the paediatric population in Italy's Lombardy Region
Electrocardiogram changes and arrhythmias in venlafaxine overdose
Cetirizine-induced anaphylaxis
Acute oxcarbazepine overdose in an autistic boy
Translation Section